Related references
Note: Only part of the references are listed.High Interferon-γ Uniquely in Vδ1 T Cells Correlates with Markers of Inflammation and Axonal Damage in Early Multiple Sclerosis
Avadhesh Kumar Singh et al.
FRONTIERS IN IMMUNOLOGY (2017)
Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment response
Manuel Comabella et al.
CURRENT OPINION IN NEUROLOGY (2016)
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
Harald Hegen et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis
Sunny Malhotra et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Immunological differences between classical phenothypes of multiple sclerosis
Piotr Iwanowski et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Plasma Biomarkers Discriminate Clinical Forms of Multiple Sclerosis
Marta Tejera-Alhambra et al.
PLOS ONE (2015)
Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation
Athanasia Mouzaki et al.
PLOS ONE (2015)
Stage-Specific Immune Dysregulation in Multiple Sclerosis
Benjamin M. Segal
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
Body fluid biomarkers in multiple sclerosis
Manuel Comabella et al.
LANCET NEUROLOGY (2014)
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS
Amanda K. Huber et al.
NEUROLOGY (2014)
Longitudinal T cell-derived IFN-γ/IL-17 balances do not correlate with the disease course in two mouse models of experimental autoimmune encephalomyelitis
Stefanie Kuerten et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2013)
Distinct Serum Cytokine Profiles in Neuromyelitis Optica and Multiple Sclerosis
Kai Chen Wang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2013)
Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon beta-1 therapy
Gunes Esendagli et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Pathology and disease mechanisms in different stages of multiple sclerosis
Hans Lassmann
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Cytokine profile in relapsing-remitting multiple sclerosis patients and the association between progression and activity of the disease
Ana Paula Kallaur et al.
MOLECULAR MEDICINE REPORTS (2013)
Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17-and Activated B-Cells and Correlates with Progression
Jeppe Romme Christensen et al.
PLOS ONE (2013)
A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis
Maira Gironi et al.
IMMUNITY & AGEING (2013)
Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis
Hans-Peter Hartung et al.
JAMA NEUROLOGY (2013)
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Jack Antel et al.
ACTA NEUROPATHOLOGICA (2012)
被撤回的出版物: Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies (Retracted article. See vol. 17, 2016)
Amedeo Amedei et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Jeppe Romme Christensen et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Analysis of Proinflammatory and Anti-Inflammatory Cytokine Serum Concentrations in Patients With Multiple Sclerosis by Using a Multiplexed Immunoassay
Thomas B. Martins et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature
Pawel Muranski et al.
IMMUNITY (2011)
Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: Prospective clinical and MRI follow-up study
Sanna Hagman et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis
Z. Mikulkova et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Progressive Multiple Sclerosis: Characteristics and Management
Kathleen Hawker
NEUROLOGIC CLINICS (2011)
Human TH17 Cells Are Long-Lived Effector Memory Cells
Ilona Kryczek et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Interferon-β exacerbates Th17-mediated inflammatory disease
Robert C. Axtell et al.
TRENDS IN IMMUNOLOGY (2011)
Th17/Th1 phenotype in demyelinating disease
L. J. Edwards et al.
CYTOKINE (2010)
T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
Robert C. Axtell et al.
NATURE MEDICINE (2010)
Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
Verena Brucklacher-Waldert et al.
BRAIN (2009)
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Josa M. Frischer et al.
BRAIN (2009)
Unlike Th1, Th17 Cells Mediate Sustained Autoimmune Inflammation and Are Highly Resistant to Restimulation-Induced Cell Death
Guangpu Shi et al.
JOURNAL OF IMMUNOLOGY (2009)
IL17 and IFNγ production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis
Giovanni Frisullo et al.
CYTOKINE (2008)
T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis
Chris J. Hedegaard et al.
IMMUNOLOGY (2008)
A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis
Howard L. Weiner
JOURNAL OF NEUROLOGY (2008)
Cell surface adhesion molecules and cytokine profiles in primary progressive multiple sclerosis
Maritta Ukkonen et al.
MULTIPLE SCLEROSIS (2007)
The immunopathology of multiple sclerosis:: An overview
Hans Lassmann et al.
BRAIN PATHOLOGY (2007)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression
IR Moldovan et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Primary and secondary progressive multiple sclerosis
S Vukusic et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Serum cytokine levels do not correlate with disease activity and severity assessed by brain MRI in multiple sclerosis
J Kraus et al.
ACTA NEUROLOGICA SCANDINAVICA (2002)
Cytokine and IL-12 receptor mRNA discriminate between different clinical subtypes in multiple sclerosis
AHH van Boxel-Dezaire et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease
J Killestein et al.
MULTIPLE SCLEROSIS (2001)